or Try an Advanced Search...

    ETF Components for BIS - ProShares UltraShort Nasdaq Biotechnology


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AMGN B -0.45 8.14
    GILD C -2.65 7.41
    VRTX B -0.74 7.21
    BIIB C -1.84 6.12
    ILMN F -0.22 5.67
    REGN B -1.97 4.13
    INCY C -2.30 2.09
    BMRN D -1.51 1.91
    ALNY A 0.43 1.60
    VTRS F -0.48 1.35
    SNY B 0.66 1.29
    NBIX C 0.54 1.16
    SRPT C -0.71 1.15
    NVCR D 0.42 1.10
    JAZZ F -1.48 1.03
    TECH D 0.29 1.02
    IONS B 1.02 1.02
    GH C -1.59 0.96
    AMRN F -2.64 0.85
    MRNA D -0.96 0.83
    BGNE F 2.81 0.83
    ACAD D -1.58 0.81
    ASND C -1.53 0.77
    EXEL C -0.86 0.73
    ARWR C -0.59 0.65
    BLUE F -0.95 0.65
    BBIO D 0.36 0.51
    ALLK F -9.59 0.49
    UTHR B -1.90 0.49
    NKTR D 11.11 0.48
    SAGE F -1.85 0.48
    BPMC B -1.21 0.48
    FGEN F -7.00 0.47
    DCPH A 0.00 0.43
    AGIO C -0.07 0.43
    CRSP F 1.48 0.42
    RARE F -1.83 0.42
    ADPT D 0.59 0.42
    MEDP C -0.33 0.40
    PTCT D 2.01 0.40
    ARGX B -0.05 0.40
    AXSM B 1.62 0.38
    ALLO F -3.70 0.37
    GRFS F 1.84 0.36
    IOVA F -4.40 0.36
    ALKS D 0.17 0.36
    KOD F -1.79 0.35
    HALO B 1.38 0.35
    QURE F -2.49 0.35
    FOLD F -0.41 0.32
    APLS F 1.23 0.31
    XNCR F 1.92 0.26
    MYGN B 0.77 0.26
    DNLI C -2.02 0.26
    ZLAB F -0.86 0.24
    IRWD F -1.77 0.24
    ARVN F -3.82 0.24
    INSM C -3.88 0.23
    FATE F -1.86 0.23
    PCRX F -4.75 0.22
    GLPG F -1.78 0.22
    ITCI C 0.77 0.21
    RGNX F 0.65 0.21
    ESPR C 0.85 0.19
    EDIT F 2.64 0.19
    LGND B -2.46 0.19
    INVA B -1.03 0.18
    VCYT C 0.99 0.18
    ALEC F 1.61 0.18
    TBPH F 2.28 0.17
    YMAB D 0.09 0.16
    CHRS F 0.00 0.16
    HCM D 1.74 0.15
    NGM D 0.00 0.15
    SUPN F 0.93 0.15

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Pain Immune System Immunology Infectious Diseases S&P 500 Disease Genetics Inflammation Monoclonal Antibodies Nasdaq 100 Organ Systems Cholesterol Diabetes
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies

    Recent News for ProShares UltraShort Nasdaq Biotechnology & its Holdings

    Date Stock Title
    Jul 3 TECH 'Breaking Up Google Would Drive 10%-15% Upside' For Shareholders, Analyst Says
    Jul 3 PCRX Pacira downgraded at Barclays following generic Exparel approval
    Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 MRNA GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
    Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
    Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
    Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
    Jul 3 TECH Tesla Stock Soars On Q2 Delivery Beat: Chart Signals Strong Bullish Momentum
    Jul 3 MRNA GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 INSM Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
    Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
    Jul 3 MRNA Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
    Jul 3 SRPT Best Momentum Stocks to Buy for July 3rd
    Jul 3 TECH Amazon Vs. Apple: The Showdown At All-Time Highs
    Jul 3 TECH Broadcom Up 10% Post-Stock Split: Strong Bullish Indicators With 12 Days To Go
    Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
    Jul 3 INSM Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
    Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
    Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
    Jul 3 GRFS Grifols shareholder Scranton inks debt deal for plasma unit
    The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF Inverse ETF Bear Market ETF Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
    Back to the Main BIS Page...